June 2026 FDA Recall Methohexital Sodium by Onesource Specialty Pharma Limited
D-0662-2026 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Onesource Specialty Pharma Limited on June 7, 2026 for the product Methohexital Sodium. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0662-2026

Reason for Recall
Failed Impurities/Degradation Specifications
Initiated
06-07-2026
Reported
07-15-2026
Quantity
4284 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
ONESOURCE SPECIALTY PHARMA LIMITED
Nationwide within the United States
Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31

Batch or Lot Expiration Information

Lot# : 7000612A, Exp. Date 1/2028

Affected Packages Involved in this Recall